NASDAQ · Shell Companies

5:01 Acquisition Corp. (FVAM) Stock

$10.00 -0.20% NASDAQ: FVAM Financial Services

5:01 Acquisition Corp. is not currently engaged in substantial operational activities.

Valuation

MetricValue
Price$10.00
Market Cap$106.57M
P/E Ratio-103.09
P/B Ratio1.34
P/S Ratio0.00
EPS (TTM)$-0.10
52-Week High$10.14
52-Week Low$9.75
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-1.29%
ROA-1.25%
ROCE-1.26%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.92

Annual Financials (USD)

Metric20202021
Revenue$0$0
Operating Profit$-1.0M$-1.0M
Net Profit$-1.0M$-1.0M
EPS$-0.08$-0.10
Op Margin——

Balance Sheet (USD)

Metric20202021
Total Assets$84.0M$83.0M
Total Liabilities$3.0M$3.0M
Cash$1.0M$0
Borrowings$0$0

Latest News

Quarterly Activities Report June 2026 ACCESS Newswire · Jul 31, 2026 Ex-death row inmate sues Ohio police over 'planted' evidence USA TODAY · Jul 31, 2026 AMC credit upgrade comes with a catch TheStreet · Jul 31, 2026 SK Hynix Trader Turns $2.26M Loss Into $6.44M Profit on Earnings Spike BeInCrypto · Jul 31, 2026 Amorepacific Holdings Signs Strategic Investment Agreement with HIGHER Corporation on Beauty and Medical Aesthetics Collaboration PR Newswire · Jul 31, 2026

Cash Flow (USD)

Metric20202021
Operating Cash Flow$0$-1.0M
Investing Cash Flow$0$0
Financing Cash Flow$0$0
Net Cash Flow$1.0M$-1.0M
Free Cash Flow$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.01
EV / EBITDA-101.47
FCF Yield-0.76%
Quick Ratio1.92
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLUABlueRiver Acquisition Corp. $11.00 +0.09% -25.00 $105.11M 0.00%
FZTFAST Acquisition Corp. II $7.76 -30.90% — $98.50M 0.00%
IGACInvest Green Acquisition Corp. $10.13 +0.40% 105.41 $183.56M 0.00%
LIONULionheart III Corp $7.05 -27.91% 0.00 $111.49M 0.00%
PLMIPlum Acquisition Corp. I $9.00 -24.87% -75.00 $100.95M 0.00%

About 5:01 Acquisition Corp.

5:01 Acquisition Corp. is not currently engaged in substantial operational activities. Its primary purpose involves pursuing and completing a business combination with one or more existing enterprises. This could take various forms, such as a merger, an exchange of equity, the acquisition of assets, a stock purchase, a financial restructuring (recapitalization), or a corporate reorganization. The entity was established in 2020 and operates from its San Francisco, California, headquarters.

5:01 Acquisition Corp. is headquartered in US.

5:01 Acquisition Corp. (FVAM) stock trades at $10.00 with a market capitalization of $106.57M. The stock is valued at a negative price-to-earnings (P/E) ratio of -103.09, reflecting a net loss over the last twelve months, price-to-book of 1.34, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.75 and $10.14, and currently trades 1.4% below its 52-week high.

On profitability, 5:01 Acquisition Corp. generates a return on equity (ROE) of -1.29% (negative, reflecting a net loss), return on capital employed of -1.26%.

Related Financial Services Stocks

BRK.A Berkshire Hathaway Inc. $733370.00 +0.00% BRK.B Berkshire Hathaway Inc. New $482.70 +0.00% JPM JP Morgan Chase & Co. $332.99 +0.47% V Visa Inc. $385.45 +2.76% MA Mastercard Incorporated $589.14 +2.66% BAC Bank of America Corporation $54.32 +1.32% HSBC HSBC Holdings, plc $92.98 +0.40% MS Morgan Stanley $190.02 +1.38% RY Royal Bank Of Canada $191.91 +0.71% GS Goldman Sachs Group, Inc. (The) $895.32 +1.44% WFC Wells Fargo & Company $83.55 +1.85% MUFG Mitsubishi UFJ Financial Group, Inc. $22.38 -0.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)Exxon Mobil (XOM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.